Fundraising Fox리가켐바이오
1 known investors
Find your way into 리가켐바이오
Sign up to see every warm intro you have to 리가켐바이오
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 리가켐바이오 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
LigaChemBio is a biotechnology company focused on drug development, particularly in ADC (antibody-drug conjugate) and small molecule therapeutics. The company develops and partners on therapeutic pipelines for pharmaceutical applications.
Investors · 1
Related companies · 3
LigachembioLigaChemBio is a biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) and small molecule therapeutics, with proprietary ADC technology and a drug development pipeline. The page shown is an investor disclosure section listing regulatory filings.
CStone PharmaceuticalsHong Kong-listed (HKEX: 2616) Chinese biopharmaceutical company developing oncology, immunology and inflammation therapies.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies working in the same space as 리가켐바이오.
Frequently asked questions
- What does 리가켐바이오 do?
- LigaChemBio is a biotechnology company focused on drug development, particularly in ADC (antibody-drug conjugate) and small molecule therapeutics. The company develops and partners on therapeutic pipelines for pharmaceutical applications.
- Who are 리가켐바이오's investors?
- 리가켐바이오's investors include Solidus Investment.